Ethnic Variations In Anti-Depressant Response
Ethnic Variations In Anti-Depressant Response
批准号:
6383272
负责人:
HECTOR FRANKLIN MYERS
金额:
$17.43万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-22 至 2006-06-30
关键词:
African American alleles antidepressants behavioral /social science research tag biotransformation caucasian American clinical trials cytochrome P450 drug adverse effect drug metabolism drug screening /evaluation genetic polymorphism human subject human therapy evaluation longitudinal human study major depression mental disorder chemotherapy outcomes research patient oriented research pharmacogenetics pharmacokinetics racial /ethnic difference remission /regression serotonin transporter social psychology
中文摘要
描述:(申请人提供)尽管最近取得了显著的进展
在几十年的现代心理药物治疗中,患者在他们的
对抗抑郁药物的反应,从完全缓解到完全治疗
失败了。负面影响,通常令人烦恼,有时还会危及生命,
继续对患者和临床医生构成重大挑战。
造成这种差异的机制仍然知之甚少。在……里面
此外,尽管不太受重视,但在
精神药物反应经常存在。……领域的最新发展
药物遗传学表明遗传因素可能在很大程度上解释了
这些不同的反应。特定的遗传多态影响
5-羟色胺(SERT)系统的功能被认为可以预测
抗抑郁药的效果。同样,基因突变也被证明是有效的
对多种药物代谢产物表达的主要影响
酶,包括大多数细胞色素P-450酶(例如,CYP2C19和
对大多数抗抑郁药物的生物转化起作用。
控制这些酶的基因的多态性已经被发现是强烈的
与各种副作用的倾向有关。大写字母
关于这些新的发展,拟议的研究将检验其预测价值
在400名患者(200名非裔美国人)中发现其中一些基因多态
和200名高加索人)与DSM-IV重度抑郁症前瞻性治疗
西酞普兰(CIT)。据推测,影响细胞功能的突变
SERT将预测对CIT的反应,CYP2CI 9基因多态性将与
介绍了CiT的副作用和药代动力学。包括
两个对比群体,非裔美国人和高加索人,他们的基因突变
明显不同的模式,将使我们能够研究
这些差异会影响他们的抗抑郁反应模式,以及
这种联系可以在不同的种族群体中“复制”。此外,非洲裔美国人的
对抗抑郁药物的反应很少有系统的研究,
特别是在对照临床试验的背景下。因此,除了
解决与临床药物遗传学相关的问题,由此得出的数据
三个站点(港湾-加州大学洛杉矶分校、加州大学洛杉矶分校/国王-德鲁和雪松-西奈医疗中心)
合作的ROL项目还应有助于弥合关键的知识差距
关于非洲裔美国人患有重大疾病的治疗
抑郁症。
英文摘要
DESCRIPTION: (provided by applicant) Despite remarkableprogress in recent
decades inmodem psychopharmacotherapy, patientsvary substantially in their
response toantidepressants, ranging from total remission to complete treatment
failure. Adverse effects, often bothersome and occasionally life-threatening,
continue to representsignificant challenges to patients and clinicians.
Mechanisms responsible for such variability remain poorly understood. In
addition, although less appreciated, substantial cross-ethnic variations in
psychotropic responses often exist. Recent developments in the field of
pharmacogenetics indicate that genetic factorsmay account for a large part of
these differences in response. Specific genetic polymorphisms affecting the
function of the serotonin (SERT) system has been postulated to predict the
effect ofantidepressants. Similarly, geneticmutations have been shown to exert
a predominant influence on the expression of a number of drug-metabolizing
enzymes, including most of the cytochrome P-450 enzymes (e.g., CYP2C19and
CYP3A4) that are responsible for the biotransformation of most antidepressants.
Polymorphisms ofgenes controlling these enzymes have been found to be strongly
associated with the propensity for variouskinds of side effects. Capitalizing
on these new developments, the proposed study will examine the predictive value
of some of these genetic polymorphisms in 400 patients (200 African Americans
and 200 Caucasians)with DSM-IV major depression prospectively treated with
citalopram (CIT). It is postulated that mutations affecting the function of
SERT will predict responses toCIT, polymorphism ofCYP2CI 9 will beassociated
with the side effect profiles and pharmacokinetics ofCiT. The inclusion of the
two comparison groups, African Americans and Caucasians, whose genetic mutation
patterns divergesignificantly from each other,will allow us to examine how
these differences affect their antidepressant response patternsand whether the
associationsare 'replicable' across ethnic groups. Also,African Americans'
response to antidepressants has rarelybeen studied in a systematic fashion,
particularly in the Context of controlled clinical trials. Thus, in addition to
addressing issues related to clinical pharmacogenetics, data derived from this
three-site (Harbor-UCLA, UCLA/King-Drew and Cedars-Sinai Medical Centers)
collaborative ROl project should also serve to bridge crucial knowledge gaps
regarding the treatment of African American patients suffering from major
depression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ETHNIC VARIATIONS IN ANTIDEPRESSANT RESPONSE IN AFRICAN AMERICANS
-
批准号:7609664
-
项目类别:
-
资助金额:$1.94万
-
财政年份:2007
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BIOBEHAVIORAL EFFECTS OF MINDFULNESS-BASED STRESS REDUCTION IN HIV
-
批准号:7718006
-
项目类别:
-
资助金额:$11.95万
-
财政年份:2007
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BIOBEHAVIORAL EFFECTS OF MINDFULNESS-BASED STRESS REDUCTION IN HIV
-
批准号:7606819
-
项目类别:
-
资助金额:$11.18万
-
财政年份:2007
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
ETHNIC VARIATIONS IN ANTIDEPRESSANT RESPONSE IN AFRICAN AMERICANS
-
批准号:7381048
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2006
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BASIC MECHANISMS OF MEDITATION & CVD IN OLDER AFRICAN AMERICANS
-
批准号:7169111
-
项目类别:
-
资助金额:$1.98万
-
财政年份:2005
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
STRESS REDUCTION & ATHEROSCLEROTIC CVD IN BLACKS
-
批准号:7169110
-
项目类别:
-
资助金额:$1.98万
-
财政年份:2005
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BASIC MECHANISM OF MEDITATION & CVD IN AFRICAN AMERICANS
-
批准号:7011628
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2004
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
Stress Reduction & Atherosclerotic CVD in Blacks
-
批准号:7011627
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2004
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
Ethnic Variations In Anti-Depressant Response
-
批准号:6539207
-
项目类别:
-
资助金额:$16.76万
-
财政年份:2001
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
Ethnic Variations In Anti-Depressant Response
-
批准号:6904476
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2001
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
Ethnic Variations In Anti-Depressant Response
-
批准号:6792074
-
项目类别:
-
资助金额:$16.57万
-
财政年份:2001
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
Ethnic Variations In Anti-Depressant Response
-
批准号:6613320
-
项目类别:
-
资助金额:$19.52万
-
财政年份:2001
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BIOPSYCHOSOCIAL BASES OF ETHNIC DIFFERENCES IN DEPRESSION
-
批准号:6314412
-
项目类别:
-
资助金额:$11.28万
-
财政年份:2000
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BIOPSYCHOSOCIAL BASES OF ETHNIC DIFFERENCES IN DEPRESSION
-
批准号:6111515
-
项目类别:
-
资助金额:$11.28万
-
财政年份:1999
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
ALCOHOL IN RISK BEHAVIORS AND NEUROBEHAVIORAL STATUS
-
批准号:6168685
-
项目类别:
-
资助金额:$10.02万
-
财政年份:1999
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
ALCOHOL IN RISK BEHAVIORS AND NEUROBEHAVIORAL STATUS
-
批准号:2795832
-
项目类别:
-
资助金额:$11.01万
-
财政年份:1999
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BIOPSYCHOSOCIAL BASES OF ETHNIC DIFFERENCES IN DEPRESSION
-
批准号:6273467
-
项目类别:
-
资助金额:$15.91万
-
财政年份:1998
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
BIOPSYCHOSOCIAL BASES OF ETHNIC DIFFERENCES IN DEPRESSION
-
批准号:6243125
-
项目类别:
-
资助金额:$17.2万
-
财政年份:1997
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
THE ROLE OF THE FAMILY IN STROKE AND STROKE PREVENTION
-
批准号:6098573
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1995
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
NIMH INSTITUTIONAL CLINICAL TRAINING
-
批准号:2287296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1989
-
负责人:HECTOR FRANKLIN MYERS
-
依托单位:
海外基金